Skip to main content
Log in

Neue Substanzen "lebensrettend"

Salvage-Therapie bei 65-Jährigem mit multiresistenter HIV-Infektion

Case Report: New substances for salvage therapy in multiresistant HIV infection

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ines Schroeder.

Ethics declarations

IS: Es bestehen keine Interessenkonflikte. US: Vortragstätigkeit und Kostenerstattung: Gilead Sciences GmbH, ViiV Healthcare GmbH, Janssen Cilag GmbH. Beratertätigkeit: ViiV Healthcare GmbH, Gilead Sciences GmbH.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schroeder, I., Seybold, U. Salvage-Therapie bei 65-Jährigem mit multiresistenter HIV-Infektion. MMW - Fortschritte der Medizin 165 (Suppl 2), 39–41 (2023). https://doi.org/10.1007/s15006-023-2564-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-023-2564-1

Keywords:

Navigation